Purchase Short-Term Access

Thromboprophylaxis with rivaroxaban or enoxaparin did not differ for major bleeding or other safety outcomes in hip arthroplasty

Pieter W. Kamphuisen, MD

Annals of Internal Medicine 2008;149:JC4-6. doi:10.7326/0003-4819-149-8-200810210-02006

Purchase Online access to this article for 24 hours

Annals of Internal Medicine

Forgot Your Password?

to gain full access to the content and tools.

Learn more about subscription options

Forgot your password?

Enter your username and email address. We'll send you a reminder to the email address on record.

Username* (Required)

Email Address* (Required)